Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. 1988

P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
Institut für Organische Chemie und Biochemie, Universität Freiburg i. Br., Federal Republic of Germany.

Glutathione reductase from human erythrocytes was inhibited by incubation with the drugs 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea (HeCNU) under quasi-physiological conditions. For reference purposes, iodoacetamide was used for inactivating alkylation of the enzyme. In each case the modified glutathione reductase was crystallized and its structure determined. These analyses showed that in all experiments the enzyme had reacted at the distal sulfur, that is at the thiol of Cys-58, and virtually nowhere else in the visible structure. The electron density of the HeCNU derivative at 0.3 nm resolution is consistent with a 2-hydroxyethyl group. This alkyl moiety has recently been identified by chemical analysis [Schirmer, R. H., Schöllhammer, T., Eisenbrand, G. and Krauth-Siegel, R. L. (1987) Free Radical Res. Commun. 3, 3-12]. The 0.2 nm resolution electron-density map of the BCNU-derivatized enzyme cannot be explained by a 2-hydroxyethyl group. Instead the modification appears as a carbamoyl moiety containing at least five non-hydrogen atoms. In this derivative the distal cysteine is forced into an unusual conformation.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D002330 Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) BCNU,1,3-Bis(2-Chloroethyl)-1-Nitrosourea,BiCNU,FIVB,N,N'-Bis(2-Chloroethyl)-N-Nitrosourea,Nitrumon
D003461 Crystallography The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystallographies
D005980 Glutathione Reductase Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2. Glutathione-Disulfide Reductase,Reductase, Glutathione,Reductase, Glutathione-Disulfide
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions

Related Publications

P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
July 1983, The Journal of laboratory and clinical medicine,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
March 1979, Clinica chimica acta; international journal of clinical chemistry,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
July 1989, The Journal of pharmacology and experimental therapeutics,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
June 1983, Research communications in chemical pathology and pharmacology,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
April 1985, The Journal of laboratory and clinical medicine,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
October 1979, Journal of medicinal chemistry,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
February 1974, Cancer research,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
April 1982, Journal of the National Cancer Institute,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
December 1993, The Journal of clinical investigation,
P A Karplus, and R L Krauth-Siegel, and R H Schirmer, and G E Schulz
February 1984, European journal of biochemistry,
Copied contents to your clipboard!